NCT04534699View on ClinicalTrials.gov

Pharmacokinetics of KBP-5074 in Patients With Moderate Hepatic Impairment

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

August 27, 2020

Primary Completion Date

November 19, 2020

Study Completion Date

November 19, 2020

Conditions

Moderate Hepatic ImpairmentHealthy

Interventions

DRUG

KBP-5074

KBP-5074 tablet

Trial Locations (3)

32809

Orlando Clinical Research Center (OCRC), Orlando

78215

Texas Liver Institute (TLI), San Antonio

78229

Clinical Trials of Texas (CTT), San Antonio

Sponsors

Lead Sponsor

KBP Biosciences

Collaborators (1)

All Listed Sponsors

collaborator

Covance

INDUSTRY

lead

KBP Biosciences

INDUSTRY